2'-fluorothymidine has been researched along with alovudine in 6 studies
| Studies (2'-fluorothymidine) | Trials (2'-fluorothymidine) | Recent Studies (post-2010) (2'-fluorothymidine) | Studies (alovudine) | Trials (alovudine) | Recent Studies (post-2010) (alovudine) |
|---|---|---|---|---|---|
| 10 | 0 | 8 | 594 | 83 | 320 |
| 187 | 18 | 39 | 594 | 83 | 320 |
| Protein | Taxonomy | 2'-fluorothymidine (IC50) | alovudine (IC50) |
|---|---|---|---|
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herdewijn, P; Munier-Lehmann, H; Pochet, S; Van Calenbergh, S; Van Rompaey, P; Vanheusden, V | 1 |
| Bergström, M; Fasth, KJ; Långström, B; Lu, L; Samuelsson, L; Sato, K | 1 |
| Grierson, JR; Jordan, R; Krohn, KA; Schwartz, JL; Tamura, Y | 1 |
| Alauddin, MM; Bornmann, W; Gelovani, JG; Mawlawi, O; Mukhopadhyay, U; Nishii, R; Pal, A; Volgin, AY | 1 |
| Emerick, LE; Krohn, KA; Plotnik, DA; Schwartz, JL; Unadkat, JD | 1 |
| Collins, JM; Douglas, KA; Jones, SK; Lawhorn-Crews, JM; Mangner, TJ; McHugh, CI; Modi, D; Shields, AF | 1 |
6 other study(ies) available for 2'-fluorothymidine and alovudine
| Article | Year |
|---|---|
Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Topics: Antitubercular Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Kinetics; Mycobacterium tuberculosis; Nucleoside-Phosphate Kinase; Structure-Activity Relationship; Thymidine; Thymine Nucleotides | 2003 |
Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Topics: Animals; Arabinofuranosyluracil; Bromine Radioisotopes; Bromouracil; Cell Division; Dideoxynucleosides; DNA; Fluorine Radioisotopes; Male; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed | 2002 |
Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
Topics: Animals; Arabinofuranosyluracil; Cell Division; Cell Line, Tumor; Dideoxynucleosides; DNA; Drug Delivery Systems; Humans; Metabolic Clearance Rate; Mice; Neoplasm Staging; Neoplasms; Radiopharmaceuticals; Thymidine; Thymidine Kinase; Tomography, Emission-Computed; Tritium | 2003 |
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
Topics: Animals; Arabinofuranosyluracil; Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Topics: Arabinofuranosyluracil; Biological Transport; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Equilibrative Nucleoside Transport Proteins; Humans; Kinetics; Neoplasms; Positron-Emission Tomography; Thymidine; Tritium | 2010 |
Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arabinofuranosyluracil; Capecitabine; Dideoxynucleosides; Female; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |